[Usefulness of ARB in heart failure].

Hiroyuki Tsutsui

研究成果: ジャーナルへの寄稿総説査読

抄録

An angiotensin receptor blocker (ARB) is recommended as an alternative in patients with heart failure and left ventricular ejection fraction less than 40% intolerant of an ACE inhibitor. In these patients, an ARB reduces the risk of death from a cardiovascularcause or hospital admission for worsening heart failure. It is also recommended in patients with heart failure who remain symptomatic despite optimal treatment with an ACE inhibitor and beta-blocker. Treatment with an ARB improves ventricular function and patient well-being, and reduces hospital admission for worsening heart failure. In patients with heart failure and preserved left ventricular ejection fraction, although no treatment has yet been shown, convincingly, to reduce morbidity and mortality, adequate treatment of hypertension is important and ARB is considered to be able t o reduce the risk of admissionsfor heart failure.

本文言語英語
ページ(範囲)751-757
ページ数7
ジャーナルNippon rinsho. Japanese journal of clinical medicine
67
4
出版ステータス出版済み - 4月 2009
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 医学一般

フィンガープリント

「[Usefulness of ARB in heart failure].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル